Supha Pharmachem rights issue
REMLIFE
0.83
0.01 (-1.19%)Last updated on 24 Dec, 2025 | 15:55 IST
BUYSELL
Today's High
0.87
Today's Low
0.82
52 Week Low
0.80
52 Week High
4.27
The current prices are delayed, login to your account for live prices
Login Supha Pharmachem Right Issue Details
Record Date
15-Apr-2025
Price
₹0
Ratio
61:50
Face Value
1
Supha Pharmachem has announced a Rights Issue to raise funds. The record date for this issue is 15-Apr-2025, while the issue price has been set at ₹0 per share. The rights ratio stands at 61:50, meaning eligible shareholders will receive the right to apply for additional shares in this proportion to their existing holdings. Each share carries a face value of ₹1.
Upcoming Rights Issue Of Shares
View More| Company | Rights Ratio | Announcement | Record Date | Rights Date |
|---|---|---|---|---|
| Hilton Metal Forging Ltd. | 14:29 | 03-Dec-2025 | 26-Dec-2025 | 26-Dec-2025 |
Supha Pharmachem FAQs
The subscription period for Supha Pharmachem’s rights issue is 22-01-2025 to 15-04-2025. The record date will be 15-04-2025. The subscription window period is usually 15 to 30 days.
As per the ratio of 61:50, the issue price of the shares under Supha Pharmachem’s right issue on the record date of 15-04-2025 is 0 per equity share.
You can apply for Supha Pharmachem’s right issue online if your bank supports the Applications Supported by Blocked Amount (ASBA) process.
For offline, Supha Pharmachem’s Registrar and Transfer Agent (RTA) sends the Composite Application Form (CAF) to each shareholder entitled to receive the Rights Issue. Fill out and submit the form to a Self-Certified Syndicate Bank (SCSB) branch (WEB).
Alternatively, you can use your bank account sharing the same PAN number as your Choice Demat account to apply for Supha Pharmachem's rights issue.
For offline, Supha Pharmachem’s Registrar and Transfer Agent (RTA) sends the Composite Application Form (CAF) to each shareholder entitled to receive the Rights Issue. Fill out and submit the form to a Self-Certified Syndicate Bank (SCSB) branch (WEB).
Alternatively, you can use your bank account sharing the same PAN number as your Choice Demat account to apply for Supha Pharmachem's rights issue.
The record date for Supha Pharmachem rights issue 2025 is 15-04-2025
The last day to apply for Supha Pharmachem’s rights issue is 15-04-2025. This date typically falls within a period of 15 to 30 days, from the Rights Issue Opening Date, which in this case is 22-01-2025.
Yes, subscribing to Supha Pharmachem’s right issue has certain tax implications:
- Subscription: There’s no immediate tax liability. The cost of acquisition is the subscription price plus transaction charges.
- Capital Gains on Sale:
- Short-Term: Gains from shares sold within 12 months are taxed at 20%.
- Long-Term: Gains from shares held over 12 months are taxed at 12.5% (exceeding ₹1.25 lakh annually).
- Renunciation:
- Selling rights entitlement attracts capital gains tax.
- Gifted rights have no immediate tax but may impact the recipient later.
- Dividend Income: Taxed at the shareholder's applicable slab rate.
